Jul 13, 2021CRISPRCRISPR/Cas9 Gene EditingX-linked RP caused by RPGR mutations, an attractive target for gene therapy because of its clinical severity and large number of patients.
Mar 7, 2021CRISPRGenome Editing in Retinal Diseases using CRISPR TechnologyBy: Glenn Yiu, MD, PhD - Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, California Ophthalmology
Jan 31, 2020CRISPRWeek in review: CRISPR start, RP first, 50-year caseBy Keng Jin Lee and Kanaga Rajan Published JAN 31, 2020